| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.09 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.09 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.081 | 0.1 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.075 | 0.1 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.1 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | epigallocatechin-3-monogallate | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.1 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.1 |